Manufacturing and supply chain solutions specialist Jabil has acquired CDMO Pharmaceutics International (Pii).
The transaction, which was completed on February 3, 2025, will see Pii's volume aseptic filling, lyophilisation and oral solid dose manufacturing capabilities incorporated into Jabil's current pharmaceutical service offerings.
This will add to the company's current parenteral drug delivery services, covering products such as auto-injectors, inhalers and body pumps.
Under the terms of the agreement, Jabil will also take ownership of Pii's US 360,000 sqft development and manufacturing site in Hunt Valley, Maryland.
The site is capable of the GMP manufacture of highly potent compounds, oral dosage forms and injectables, though it is also equipped for formulation development and analytics.
Through this acquisition, Pii will now have access to automation and supply chain technologies, as well as an expanded global infrastructure.
“As the pace of healthcare innovation accelerates, pharmaceutical companies need partners who can help them scale rapidly with a focus on quality and safety. Jabil and Pii’s combined capabilities can provide end-to-end support for pharmaceutical customers, offering one safe, trusted pair of hands to simplify their entire supply chain,” said Mike Mahaz, SVP, Global Business Units, Healthcare, at Jabil.
“We believe the addition of Pii’s capabilities, supported by over 300 team members, is a perfect fit for Jabil and our customers,” said VP of Pharmaceutical Solutions at Jabil, James O’Gorman.
“The convergence of Jabil’s and Pii’s complementary capabilities will bolster Jabil's customer offering and support business growth potential as we enter the CDMO market.”
“This acquisition marks an exciting new chapter for Pii. We look forward to leveraging Jabil’s extensive expertise to accelerate our mission of delivering best-in-class drug development and manufacturing solutions to our customers and ultimately the patients we serve,” said John Fowler, President and CEO at Pii.
James Gale, Chair of Pii and Managing Director of Signet Healthcare Partners, concluded “Jabil is the perfect owner to continue the momentum of the business. With their resources and capabilities, we believe our customers and employees will be well served going forward.”